This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braun, S. Articles by Hepp, F. Search for Related Content PubMed PubMed Citation Articles by Braun, S. Articles by Hepp, F. Social Bookmarking                            What's this?

Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy

From the I. Frauenklinik and Department of Gynecological Pathology, Klinikum Innenstadt, Ludwig-Maximilians-University, München; Germany.

Address reprint requests to Stephan Braun, MD, Frauenklinik & Poliklinik, Klinikum rechts der Isar, Technical Universität, Ismaninger Strasse 22, D-81675 Munich, Germany; email: stephan.braun{at}lrz.tum.de

PURPOSE: In node-negative patients, of whom up to 30% will recur within 5 years after diagnosis, markers are still needed that identify patients at high enough risk to warrant further adjuvant treatment. In the present study we analyzed whether a correlation exists between microscopic tumor cell spread to bone marrow and to lymph nodes and attempted to determine which route is clinically more important.

PATIENTS AND METHODS: According to a prospective design, bone marrow aspirates and axillary lymph nodes of level I (n = 1,590) from 150 node-negative patients with stage I or II breast cancer were analyzed immunocytochemically with monoclonal anticytokeratin (CK) antibodies. We investigated associations with prognostic factors and the effect of micrometastasis on patients’ prognosis.

RESULTS: CK-positive cells in bone marrow aspirates were present in 44 (29%) of 150 breast cancer patients, whereas only 13 patients (9%) had such positive findings in lymph nodes; simultaneous microdissemination to bone marrow and lymph nodes was seen in merely two patients. No correlation of bone marrow micrometastases with other risk factors was assessed. Reduced 4-year distant disease-free and overall survival were each associated with a positive bone marrow finding (P = .032 and P = .014, respectively) but not with lymph node micrometastasis. Multivariate analysis revealed an independent prognostic effect of bone marrow micrometastasis on survival, with a hazards ratio of 6.1 (95% confidence interval, 1.2 to 31.3) for cancer-related death (P = .031) in our series.

CONCLUSION: Immunocytochemical detection of micrometastatic cells in bone marrow but not in lymph nodes is an independent prognostic risk factor in node-negative breast cancer that may have implications for surgery and stratification into adjuvant therapy trials.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Masci, L. Di Tommaso, I. Del Prato, S. Orefice, A. Rubino, G. Gullo, M. Zuradelli, R. Sacco, M. Alloisio, M. Eboli, et al. Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer Ann. Onc., November 10, 2009; (2009) mdp453v2. [Abstract] [Full Text] [PDF]

				H. P. Dhakal, B. Naume, M. Synnestvedt, E. Borgen, R. Kaaresen, E. Schlichting, G. Wiedswang, A. Bassarova, K.-E. Giercksky, and J. M. Nesland Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination Clin. Cancer Res., April 15, 2008; 14(8): 2341 - 2350. [Abstract] [Full Text] [PDF]

				L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer J. Clin. Oncol., November 20, 2007; 25(33): 5287 - 5312. [Abstract] [Full Text] [PDF]

				M. Lacroix Significance, detection and markers of disseminated breast cancer cells Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067. [Abstract] [Full Text] [PDF]

				S. Braun, F. D. Vogl, B. Naume, W. Janni, M. P. Osborne, R. C. Coombes, G. Schlimok, I. J. Diel, B. Gerber, G. Gebauer, et al. A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer N. Engl. J. Med., August 25, 2005; 353(8): 793 - 802. [Abstract] [Full Text] [PDF]

				V. Muller, N. Stahmann, S. Riethdorf, T. Rau, T. Zabel, A. Goetz, F. Janicke, and K. Pantel Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity Clin. Cancer Res., May 15, 2005; 11(10): 3678 - 3685. [Abstract] [Full Text] [PDF]

				S. A. Vantyghem, S. M. Wilson, C. O. Postenka, W. Al-Katib, A. B. Tuck, and A. F. Chambers Dietary Genistein Reduces Metastasis in a Postsurgical Orthotopic Breast Cancer Model Cancer Res., April 15, 2005; 65(8): 3396 - 3403. [Abstract] [Full Text] [PDF]

				S. Imoto, N. Wada, K. Murakami, T. Hasebe, A. Ochiai, and S. Ebihara Prognosis of Breast Cancer Patients Treated with Sentinel Node Biopsy in Japan Jpn. J. Clin. Oncol., August 1, 2004; 34(8): 452 - 456. [Abstract] [Full Text] [PDF]

				A. Gajra and S. Graziano In Reply: J. Clin. Oncol., December 15, 2003; 21(24): 4661 - 4662. [Full Text] [PDF]

				K. Pantel, V. Muller, M. Auer, N. Nusser, N. Harbeck, and S. Braun Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6326 - 6334. [Abstract] [Full Text] [PDF]

				T. G. Lugo, S. Braun, R. J. Cote, K. Pantel, and V. Rusch Detection and Measurement of Occult Disease for the Prognosis of Solid Tumors J. Clin. Oncol., July 1, 2003; 21(13): 2609 - 2615. [Full Text] [PDF]

				N. Xenidis, I. Vlachonikolis, D. Mavroudis, M. Perraki, A. Stathopoulou, N. Malamos, C. Kouroussis, S. Kakolyris, S. Apostolaki, N. Vardakis, et al. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer Ann. Onc., June 1, 2003; 14(6): 849 - 855. [Abstract] [Full Text] [PDF]

				Y.-S. Jung, K.-J. Lee, H.-J. Kim, H. E. Yim, J. S. Park, E.-Y. Soh, M.-W. Kim, and H. B. Park Clinical Significance of Bone Marrow Micrometastasis Detected by Nested RT-PCR for Keratin-19 in Breast Cancer Patients Jpn. J. Clin. Oncol., April 1, 2003; 33(4): 167 - 172. [Abstract] [Full Text] [PDF]

				R. A. Wascher, K. T. Huynh, A. E. Giuliano, N. M. Hansen, F. R. Singer, D. Elashoff, and D. S. B. Hoon Stanniocalcin-1: A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1427 - 1435. [Abstract] [Full Text] [PDF]

				A. Stathopoulou, I. Vlachonikolis, D. Mavroudis, M. Perraki, Ch. Kouroussis, S. Apostolaki, N. Malamos, S. Kakolyris, A. Kotsakis, N. Xenidis, et al. Molecular Detection of Cytokeratin-19-Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance J. Clin. Oncol., August 15, 2002; 20(16): 3404 - 3412. [Abstract] [Full Text] [PDF]

				T. E. Witzig, B. Bossy, T. Kimlinger, P. C. Roche, J. N. Ingle, C. Grant, J. Donohue, V. J. Suman, D. Harrington, J. Torre-Bueno, et al. Detection of Circulating Cytokeratin-positive Cells in the Blood of Breast Cancer Patients Using Immunomagnetic Enrichment and Digital Microscopy Clin. Cancer Res., May 1, 2002; 8(5): 1085 - 1091. [Abstract] [Full Text] [PDF]

				K. C. Redmond, J. H. Wang, K. K. Austin, N. Relihan, G. McGreal, W. O. Kirwan, D. Richardson, J. Kelly, H. P. Redmond, S. Braun, et al. Is Immunohistochemical Analysis an Appropriate Diagnostic Technique for Bone Marrow Micrometastases? J. Clin. Oncol., August 1, 2001; 19(15): 3589 - 3592. [Full Text]

				A. M. Sleeper, S. M. Sorscher, L. L. Dietrich, C. L. Loprinzi, and S. D. Thome Assessing Adjuvant Breast Cancer Therapy Benefit J. Clin. Oncol., June 15, 2001; 19(12): 3157 - 3159. [Full Text] [PDF]

				S. Braun and K. Pantel Clinical Significance of Occult Metastatic Cells in Bone Marrow of Breast Cancer Patients Oncologist, April 1, 2001; 6(2): 125 - 132. [Abstract] [Full Text]